WASHINGTON — The National Institutes of Health, thanks to Congress, will soon have an extra $500 million to spend each year on research into opioids and pain treatment. And on Tuesday, the research agency published a scientific outline showing how the increase in funding will be put to use.

An opinion piece published in the Journal of the American Medical Association adds detail to a previously announced initiative called Helping to End Addiction Long-term (HEAL), a combination of new and existing initiatives the NIH announced in April. Agency leaders wrote that the research will be split into two broad categories: improving addiction treatments and improving pain management.

Unlock this article by subscribing to STAT Plus. Try it FREE for 30 days!

GET STARTED

What is it?

STAT Plus is a premium subscription that delivers daily market-moving biopharma coverage and in-depth science reporting from a team with decades of industry experience.

What's included?

  • Authoritative biopharma coverage and analysis, interviews with industry pioneers, policy analysis, and first looks at cutting edge laboratories and early stage research
  • Subscriber-only networking events and panel discussions across the country
  • Monthly subscriber-only live chats with our reporters and experts in the field
  • Discounted tickets to industry events and early-bird access to industry reports

Leave a Comment

Please enter your name.
Please enter a comment.

  • There is no reason to believe they will do anything in a meaningful or scientific manner. The NIH has failed the American People. Somebody should have gotten concerned when they allowed pseudo science into their database. The NIH failed already, they have had 2 decades to figure this out, instead they chose to promote quackery. None of us will know how many more deaths, whatever they are appearing to do now will lead to. The number of dead Americans, is mostly censored. The NIH has failed to inject any common sense, fact based data, or science into this topic. It might be too late now.

Sign up for our Daily Recap newsletter

A roundup of STAT’s top stories of the day in science and medicine

Privacy Policy